Serina Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 01/29/2026 | 180.01 K | $344.37 K | 0.00% | 1.74% |
| WAVERLY ADVISORS, LLC | 02/17/2026 | 67.49 K | $129.11 K | 0.00% | 0.65% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 30.41 K | $58.17 K | 2.71% | 0.29% |
| LINSCOMB & WILLIAMS, INC. | 02/10/2026 | 18.80 K | $35.97 K | 0.00% | 0.18% |
| KEEL POINT, LLC | 02/12/2026 | 17.77 K | $34.00 K | 0.00% | 0.17% |
| BLACKROCK, INC. | 02/12/2026 | 17.25 K | $33.00 K | 31.45% | 0.17% |
| STATE STREET CORP | 02/13/2026 | 12.76 K | $24.41 K | 0.00% | 0.12% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 11.98 K | $22.92 K | -34.22% | 0.12% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 3.60 K | $6.89 K | 180,100.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 449 | $859 | 175.46% | 0.00% |
| UBS GROUP AG | 01/29/2026 | 433 | $829 | -87.51% | 0.00% |
| PISCATAQUA SAVINGS BANK | 01/16/2026 | 28 | $53 | 0.00% | 0.00% |
| PACIFICA PARTNERS INC. | 01/09/2026 | 8 | $17 | 0.00% | 0.00% |
| ALBION FINANCIAL GROUP /UT | 01/21/2026 | 8 | $16 | 0.00% | 0.00% |
| MORGAN STANLEY | 02/13/2026 | 8 | $15 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 3 | $6 | -98.60% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 2 | $4 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 2 | $2 | -81.82% | 0.00% |
| GLOBAL RETIREMENT PARTNERS, LLC | 02/06/2026 | 1 | $2 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISORY SERVICES NETWORK, LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Serina Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Serina Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD GROUP INC: 180,013
Waverly Advisors, LLC: 67,492
GEODE CAPITAL MANAGEMENT, LLC: 30,409
Linscomb & Williams, Inc.: 18,800
Keel Point, LLC: 17,774
BlackRock, Inc.: 17,249
2.83% of Serina Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 365.00 K shares in the last 24 months. This purchase volume represents approximately $609.55 K in transactions.